Gunderson Dettmer advised TeneoTwo on the deal. TeneoTwo, a developer of therapeutic antibodies, announced its pending acquisition by AstraZeneca, a bio-pharmaceutical company that focuses on the discovery,...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Ancora Biotech on the deal. Ancora Biotech, a California-based biotechnology company, announced its $60 million Series A financing co-led by Lightspeed Venture Partners and...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised The Athletic on its sale to The New York Times Company, assisted by Borden Ladner Gervais LLP and...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Alteryx on the deal while Gunderson Dettmer represented Trifacta, and IndusLaw represented Infosys Limited. Alteryx (NYSE: AYX), a leading provider of self-service...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Altimeter Capital and Coatue on the deal. Altimeter Capital and Coatue led the $250 million Series B financing...
You must be a Standard 1 Year member to access this content.
Goldman Sachs & Co. acted as financial advisor to Amgen and Latham & Watkins as its legal advisor. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian and...
You must be a Standard 1 Year member to access this content.
